MFG
BPMC

Merit Financial Group’s Blueprint Medicines BPMC Stock Holding History

Merit Financial Group’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,662
Closed -$213K – 1800
2025
Q2 		$213K Buy
+1,662
New +$173K ﹤0.01% 1525

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Merit Financial Group's BPMC Position: Q3 2025 in Review

Merit Financial Group sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 1,662 shares — an estimated $213K sold.

Merit Financial Group first reported a position in BPMC in Q2 2025 and held it in 1 quarter. The position peaked at $213K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Merit Financial Group reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Merit Financial Group sold 1,662 Blueprint Medicines shares in Q3 2025, an estimated $213K.
  • Merit Financial Group first reported a position in Blueprint Medicines in Q2 2025 and held it in 1 quarter.
  • Merit Financial Group's Blueprint Medicines position peaked at $213K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Merit Financial Group's 13F filing for Q3 2025, filed 20 Oct 2025.